Baird Financial Group
EDIT icon

Baird Financial Group’s Editas Medicine EDIT Stock Holding History

Baird Financial Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,169
Closed -$25.1K – 1939
2026
Q1 		$25.1K Sell
10,169
-10,701
-51% -$22.6K ﹤0.01% 1824
2025
Q4 		$42.8K Sell
20,870
-7,672
-27% -$22.1K ﹤0.01% 1781
2025
Q3 		$99K Sell
28,542
-329
-1% -$918 ﹤0.01% 1774
2025
Q2 		$63.5K Sell
28,871
-1,880
-6% -$3.08K ﹤0.01% 1755
2025
Q1 		$35.7K Hold
30,751
– – ﹤0.01% 1742
2024
Q4 		$39.1K Sell
30,751
-5,234
-15% -$13.3K ﹤0.01% 1739
2024
Q3 		$123K Sell
35,985
-477
-1% -$2.08K ﹤0.01% 1693
2024
Q2 		$170K Buy
36,462
+1,265
+4% +$7.14K ﹤0.01% 1694
2024
Q1 		$261K Buy
35,197
+6,002
+21% +$49.9K ﹤0.01% 1604
2023
Q4 		$296K Buy
29,195
+3,230
+12% +$28.4K ﹤0.01% 1522
2023
Q3 		$203K Buy
25,965
+686
+3% +$5.88K ﹤0.01% 1625
2023
Q2 		$208K Buy
25,279
+218
+0.9% +$1.9K ﹤0.01% 1607
2023
Q1 		$182K Buy
25,061
+7,904
+46% +$70.3K ﹤0.01% 1627
2022
Q4 		$152K Buy
17,157
+6,285
+58% +$69K ﹤0.01% 1628
2022
Q3 		$133K Buy
10,872
+374
+4% +$5.83K ﹤0.01% 1649
2022
Q2 		$125K Sell
10,498
-265
-2% -$3.55K ﹤0.01% 1734
2022
Q1 		$205K Buy
10,763
+800
+8% +$14.9K ﹤0.01% 1745
2021
Q4 		$265K Buy
+9,963
New +$343K ﹤0.01% 1723

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Baird Financial Group's EDIT Position: Q2 2026 in Review

Baird Financial Group sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 10,169 shares — an estimated $25.1K sold.

Baird Financial Group first reported a position in EDIT in Q4 2021 and held it in 18 quarters. The position peaked at $296K in Q4 2023. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Baird Financial Group reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • Baird Financial Group sold 10,169 Editas Medicine shares in Q2 2026, an estimated $25.1K.
  • Baird Financial Group first reported a position in Editas Medicine in Q4 2021 and held it in 18 quarters.
  • Baird Financial Group's Editas Medicine position peaked at $296K in Q4 2023.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.